AVR.AX · ANTERIS TECHNOLOGIES GLOBAL CORP.
Australia · RS rating 49 · As of 2026-10-14
| Price | 9.11 AUD |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 10 / 20 / 81 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 39 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | -7.1% |
| Sales growth Q/Q | +104.2% |
| Distance from 52-week high | +40.5% |
| Market cap (USD) | $646.9M |